Erratum: MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity

Int J Biol Sci. 2022 Nov 3;18(16):6226. doi: 10.7150/ijbs.79140. eCollection 2022.

Yingming Sun^{1

2}, Xiaoge Sun^{1

3}, Chengcheng You^{1

4}, Shijing Ma¹, Yuan Luo¹, Shan Peng¹, Fang Tang¹, Xiaoli Tian¹, Feng Wang¹, Zhengrong Huang^{1

5}, Hongnv Yu⁶, Yu Xiao^{5

7}, Xiaoyong Wang^{1

8}, Junhong Zhang^{1

8}, Yan Gong^{5

7}, Conghua Xie^{1

8}

¹ Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
² Department of Radiation and Medical Oncology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming, China.
³ Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
⁴ Department of Pathology, China Three Gorges University Medical College, Yichang, China.
⁵ Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
⁶ Central Laboratory of Xinhua Hospital of Dalian University, Department of Medical Oncology, Xinhua Hospital of Dalian University, Dalian, China.
⁷ Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
⁸ Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

Abstract

[This corrects the article DOI: 10.7150/ijbs.59430.].